Kick-Off Meeting - April 24th 2018

Kick-Off Meeting

April 24th 2018

Annual Meeting 2019 - April 4th-5th 2019

Annual Meeting 2019

April 4th-5th 2019

Sommer School 2019 - September 25th-27th 2019

Sommer School 2019

September 25th-27th 2019

Annual Meeting 2020 - January 15th-16th 2020

Annual Meeting 2020

January 15th-16th 2020

AMPro in brief

All centers of the Helmholtz Health Research Section are working together with the aim of exploring innovative prevention and treatment approaches to age-related diseases. More...

News & Events

Spring School and Final Meeting 2021

March 15th-17th 2021
Further information will be provided in time.

 

Get to know the AMPro Scientists!

Biweekly, we present you one AMPro scientist in more detail.

This time: Anne Wentink

The latest AMPro publications

Pauline Morigny and Julia Zuber et al.
High levels of modified ceramides are a definingfeature of murine and human cancer cachexia.
Journal of Cachexia, Sarcopenia and Muscle. Oct 2020.

Sara Ahmed et al.
Fitness trade-offs incurred by ovary-to-gut steroid signaling in Drosophila.
Nature. Aug 2020.

Fabio Bertan et al.
Loss of Ryanodine Receptor 2 impairs neuronal activity-dependent remodeling of dendritic spines and triggers compensatory neuronal hyperexcitability.
Cell Death & Differentiation. June 2020.

More

 

Contact - Project Management

Dr. Claudia Prothmann

Institute for Diabetes and Cancer IDC
Helmholtz Center Munich (HMGU)
Ingolstädter Landstraße 1
85764 Neuherberg
Germany
Phone: +49 89 3187-49394
mail

 

Dr. Sabine Rehberger-Schneider

Division of Signal Transduction in Cancer and Metabolism
German Cancer Research Center (DKFZ) - B140
Im Neuenheimer Feld 580
69120 Heidelberg
Germany
Phone: +49 6221 42-1628
mail

AMPro - Aging and Metabolic Programming

Most chronic diseases such as diabetes, cancer, cardiovascular, respiratory and neurodegenerative diseases as well as chronic infections increase in incidence with age. This indicates common age-related mechanisms acting jointly. Due to increasing life expectancy throughout the world, those age-related diseases are emerging as a growing challenge for patients, doctors, the healthcare system and society as a whole.

 

Among other things, the AMPro consortium is seeking out new preventive and therapeutic approaches that have a positive effect on metabolic processes. This should enable the innovative and consistent treatment of age-related diseases. The following key aspects of metabolic processes associated with aging will be investigated.

 

Metabolic pre- and reprogramming 
Prenatal and postnatal mechanisms of metabolic programming at the genetic and epigenetic levels

Inter-organ signaling
Mechanisms of organ and tissue communication

Stem cell function and tissue maintenance 
Tissue and cellular repair mechanisms

 

The long-term goal is to improve health in an aging society. AMPro creates ideal conditions for successfully tackling one of the most pressing issues in today's society and meeting the challenges of age-related diseases.